Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Mesalazine may help treat extensive alopecia areata effectively.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Finasteride can cause melasma, especially in people with darker skin.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Deep learning can accurately automate hair density measurement, with YOLOv4 performing best.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Minoxidil may help nails grow faster and stronger.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Media coverage led to more dermatologists prescribing low-dose oral minoxidil for hair loss.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Non-surgical treatments like thread lifts, PRP therapy, HIFU, and radiofrequency effectively rejuvenate and tighten facial skin.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

Autologous Micrografting Technology effectively improves hair growth and is a safe, promising option for hair restoration.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Oral tofacitinib successfully treated total body hair loss in one patient.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.